Published in Oncology Business Week, March 21st, 2010
The patent covers the use of this antigen-adjuvant family of proteins alone or when delivered via a live, attenuated Listeria vaccine. Advaxis has patents on two families of antigen-fusion proteins based upon the Listeria proteins Act-A and LLO.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week